Fast Company | Katrine Bosley's Race To Make Gene Editing A Medical Reality Fast Company ... in February—on top of $163 million in earlier funding from Bill Gates, Google Ventures, and others—Editas is the richest of a small group of startups vying to be first to market with therapies that use a groundbreaking gene- editing technology ... Editas Medicine Announces First Quarter 2016 Results and Update Editas Medicine's ( EDIT ) CEO Katrine Bosley on Q1 2016 Results - Earnings Call Transcript Editas Medicine Posts Wider Q1 Loss Vs. Street, Misses on Revenue (NASDAQ: EDIT ) |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]eople/katrine-bosleys-race-to-